Status:
COMPLETED
Aversive Therapy for Smoking Cessation
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Smoking Cessation
Eligibility:
All Genders
19-99 years
Phase:
NA
Brief Summary
The purpose of this research study is to test a new way to help people quit smoking. The PI will test acceptability and feasibility of a new device called Pavlok wearable wrist band. Participants will...
Detailed Description
The participants will be evaluated after 1 week and assessed for their ongoing participation and commitment to the study. Those still interested and eligible will be randomized to two groups described...
Eligibility Criteria
Inclusion
- Current smoker (defined by the Center for Disease Control as an "adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes ". This will be determined based on participant baseline survey.
- Interested in quitting (contemplation stage and beyond, as defined by serious consideration of quitting smoking in the next 30 days
- Subject is equal to or greater than 19 years old
- Considers themselves "tech savvy" (based on self reported 5 point likert scale)
- Must have a smart phone with blue tooth capabilities
- Willing to receive aversive therapy if assigned to this group.
Exclusion
- Anyone with a diagnosed arrhythmia or with a pacemaker or with a phobia or history of psychosis.
- Non-English speaking caregivers
- Lives outside of contiguous United States
Key Trial Info
Start Date :
July 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03450148
Start Date
July 20 2018
End Date
May 1 2021
Last Update
July 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Alabama at Birmingham
Birmingham, Alabama, United States, 35294